Although several genetic defects are accumulated in CML cells during the progression from the chronic phase towards the accelerated and blast crisis phases (see review in [4]), studies in mice transplanted with BCR/ABL transduced cells demonstrated that this oncogene is the causative agent of CML[5]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.